FibroGen Files 8-K: Material Agreement and Exhibits
Ticker: KYNB · Form: 8-K · Filed: Jul 14, 2025 · CIK: 921299
| Field | Detail |
|---|---|
| Company | Fibrogen Inc (KYNB) |
| Form Type | 8-K |
| Filed Date | Jul 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing
TL;DR
FibroGen signed a big deal, filing 8-K on July 14th.
AI Summary
On July 14, 2025, FibroGen, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements and exhibits. The company's principal executive offices are located at 350 Bay Street, Suite 100 #6009, San Francisco, California.
Why It Matters
This 8-K filing signals a significant development for FibroGen, Inc., potentially involving a new contract or partnership that could impact its financial standing and future operations.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which could represent significant opportunities or risks depending on the nature of the agreement.
Key Players & Entities
- FibroGen, Inc. (company) — Registrant
- July 14, 2025 (date) — Date of earliest event reported
- 350 Bay Street Suite 100 #6009 (address) — Principal Executive Offices
- San Francisco, California (location) — Principal Executive Offices Location
FAQ
What is the nature of the material definitive agreement entered into by FibroGen, Inc. on July 14, 2025?
The provided text does not specify the details of the material definitive agreement, only that one was entered into.
What specific financial statements and exhibits are included in this 8-K filing?
The filing indicates that financial statements and exhibits are included, but the specific content is not detailed in the provided text.
What is FibroGen, Inc.'s primary business as indicated by its SIC code?
FibroGen, Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
Where are FibroGen, Inc.'s principal executive offices located?
FibroGen, Inc.'s principal executive offices are located at 350 Bay Street, Suite 100 #6009, San Francisco, California.
What is the Commission File Number for FibroGen, Inc.?
The Commission File Number for FibroGen, Inc. is 001-36740.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding FIBROGEN INC (KYNB).